You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 110 No. 3, March 1975 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Survivors' and Nonsurvivors' Responses to Dextran 40

Hemodynamic and Oxygen Transport Changes in Critically Ill Patients

Hiroharu Matsuda, MD; William C. Shoemaker, MD

Arch Surg. 1975;110(3):301-305.


Abstract

Cardiorespiratory effects of dextran 40 administration were measured and compared retrospectively in 74 surviving and 73 nonsurviving critically ill patients. In the preinfusion control period, the survivors had higher mean arterial pressures and blood flow with lesser blood volume deficits. Dextran significantly improved pressure, blood flow, blood volume, oxygen transport, and derived calculations in both groups, but the average cardiorespiratory responses to dextran were somewhat greater in nonsurvivors than in survivors. About two thirds of the patients responded to dextran with significantly increased oxygen consumption (P <.05), suggesting that this agent improved oxygen transport by its rheologic effects on the microcirculation. The cardiorespiratory effects of dextran were slightly greater in the patients who ultimately died; nevertheless, the salutary cardiorespiratory response did not reverse the clinical course in nonsurvivors, whose perfusion defect apparently had reached irreversible proportions prior to the administration of the drug.



Author Affiliations

From the Department of Surgery, Mount Sinai School of Medicine of the City University of New York. Dr. Matsuda is with the Department of Surgery, Kyorin University School of Medicine, Tokyo, and was a Visiting Scientist with the Department of Surgery at Mount Sinai. Dr. Shoemaker is currently with the Department of Surgery, Harbor General Hospital, Torrance, Calif, and the UCLA School of Medicine, Los Angeles.


Footnotes

Accepted for publication Oct 16, 1974.

Reprint requests to Department of Surgery, Harbor General Hospital, 1000 W Carson St, Torrance, CA 90509 (Dr. Shoemaker).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Wet, dry or something else?
Bellamy
Br J Anaesth 2006;97:755-757.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.